Navigation Links
Tips from the journals of the American Society for Microbiology
Date:7/21/2009

arch has shown that GRP plays a significant role in human cancers through atypical expression of the GRP receptor and GRP binding that activates cellular signaling and results in increased cell production and tumor formation. Anti-GRP antibodies have displayed promising antitumoral activity and DNA vaccines targeting GRP are a hopeful therapeutic approach.

In the study researchers developed a novel anti-GRP DNA vaccine including various immunoadjuvants (substances to improve the immune response) and monitored anti-GRP antibody levels in vaccinated mice. Intramuscular injections induced high levels of specific antibodies against GRP as well as suppressed the growth of melanoma cells. Additionally, researchers intravenously injected cells in the lungs and found that cells were highly diminished indicating that the vaccine may also inhibit cancer from spreading.

"In conclusion, we have demonstrated for the first time that immune responses which are elicited by a novel anti-GRP DNA vaccine suppress the proliferation and growth of melanoma tumors in mice," say the researchers. "The antiangiogenesis and antimetastastic activities of this DNA vaccine suggest a novel approach against various cancers, especially malignant melanoma."

(J. Fang, Y. Lu, K. Ouyang, G. Wu, H. Zhang, Y. Liu, Y. Chen, M. Lin, H. Wang, L. Jin, R. Cao, R.S. Roque, L. Zong, J. Liu, T. Li. 2009. Specific antibodies elicited by a novel DNA vaccine targeting gastrin-releasing peptide inhibit murine melanoma growth in vitro. Clinical and Vaccine Immunology, 16. 7: 1033-1039.)


'/>"/>

Contact: Carrie Slijepcevic
cslijepcevic@asmusa.org
American Society for Microbiology
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration
2. Elsevier journals participate widely in global theme issue on poverty and human development
3. 9 SAGE journals participate in global theme issue on poverty and human development
4. Springer adds Advances in Therapy to journals portfolio
5. Launch of Innovative Journals on Quality and Performance Improvement in Medicine by Dowden Health Media
6. ScienceDirect to host French-language journals from Elsevier Masson
7. Haymarket Adds Two Cancer Journals to Its Family of Clinical Publications
8. American Heart Association Launches First of New Journals - Circulation: Arrhythmia and Electrophysiology Premieres
9. SAGE acquires 2 new medical journals
10. Pocket Reference Journals Releases Latest Edition of "All About Me" Leading Children's Immunization Journal for New Moms
11. American Journal of Nursing voted one of the most influential journals of the century

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ctoryPharma,Inc.("Victory")announcedtodaythelaunch...y,sNAPRELANfranchise. ,, NAPRELANDoseCardisdesi...ainandinflammationassociatedwithprimarydysmenorrhe...patientssufferingfromrheumatoidarthritisorosteoart...onalanti-inflammatory/analgesicactivityforalimited...
(Date:11/23/2009)...n the November issue of GIE: Gastrointestinal End...nal of the American Society for Gastrointestinal E...y found that Barrett,s esophagus was detected in s...opic screening. Also in this issue, two studies ex...om France, in the largest single-center experience...
(Date:11/23/2009)...build-up of a brain peptide called amyloid-beta. T...us of almost all drug research pursuing a cure for...But that may be counterproductive, says Dr. Inna S...iology and Pharmacology, Sackler Faculty of Medici...beta is also necessary to maintain proper brain fu...
(Date:11/23/2009)...Call/--AnnTaylorStoresCorp.announcedtodaythatitwil...sandGivingcampaign,aholidayfundraisingandawareness...armarksthethirdyearthatAnnTaylor,throughitsANNCARE...mpaignwhereweofferourshoppersanopportunitytohelpsa...hisholidayseason.ClientswhoshopatAnnTaylor,Loft,An...
(Date:11/23/2009)...ed longer-term support than most friends, relative...ing to a study of 160 patients published in the De...Nursing . , Researchers surveyed 55 patients...her with 105 who had had surgery in the last one t...in Tennessee, USA. They wanted to see if there was...
Breaking Medicine News(10 mins):Health News:Victory Pharma, Inc. Announces Launch of NAPRELAN(R) Dose Card 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 3Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 4Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 5Health News:Upending textbook science on Alzheimer's disease 2Health News:Ann Taylor Stores Corp. Returns To St. Jude Children's Research Hospital's Thanks and Giving Campaign(R) For The Third Year 2Health News:Drug side effects a key factor in reduced quality of life for kidney transplant patients 2Health News:Drug side effects a key factor in reduced quality of life for kidney transplant patients 3
...ntists from University of California have develope...cells which could help in the treatment of spinal ...ing results in the stimulation of nerve cells in l...oung and doesnot grow when it has become old, the ...
...essor Karen Gripp and his team from DuPont Hospita...ad to Costello Syndrome, scientists found that the...it was not observed in the genotype of the parents...don 12 or 13 in the H-ras gene in 85% patients. Th...
...Lancet has published a new study which challenges ...od to the heart. The study asserts that the harm i...benefits. Conventional medical wisdom states that ...ealand cite a large US study published earlier thi...
...search team of scientists at the Columbia Universi...eight when compared to keeping it off. // The key ...ppetite. The hormone helped people to avoid puttin...he metabolic thermostat of the body is reset upwar...
...galese schoolchildren took a pledge to abstain fro...DS Day. The prevailing taboos in the developing na...ntributing towards the disease spreading rapidly. ...courge is continuing to take a heavy toll in the A...
...ish researchers have expressed hope regarding the ...virus. The first phase of the clinical trials have...volunteers. DNA vaccines represent the lates... vaccines precipitate an immune response so that t...
Other Medicine News:Health News:DNA Vaccine Trials Against HIV Virus In Sweden Nurture Hope 2
(Date:11/23/2009)...ire-FirstCall/--RaptorPharmaceuticalCorp.("Raptor"...sentationofclinicaltrialdataonNGX426,theCompany,so...ntagonist,atthe12thInternationalConferenceontheMec...r20-21inSanFrancisco.TheresultsofthestudyledbyMark...eCenterforPainMedicineoftheUniversityofCaliforniaa...
(Date:11/23/2009)...ewswire-FirstCall/--NeurobiologicalTechnologies,In...ofdirectorshasdeclaredanextraordinarydividendof$0....,2009tostockholdersofrecordasofNovember30,2009.The...derapprovalofthedissolutionofNTIpursuanttoaplanofc...rdinarydividendof$0.75persharethatwaspaidtoshareho...
(Date:11/20/2009)...swire/ -- The United States Court of Appeals for ... ruling yesterday, approving a settlement in the l...utical litigation against AstraZeneca Pharmaceutic...gi-bin/prnh/20080317/AQM144LOGO ) ,, The ruling...urchased the pharmaceutical giant,s prostate cance...
Breaking Medicine Technology:Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 4Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 5Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3HEALTHeCAREERS Network Renews 2415 000 Scholarship Pledge 59787 1HEALTHeCAREERS Network Renews 2415 000 Scholarship Pledge 59787 2HEALTHeCAREERS Network Renews 2415 000 Scholarship Pledge 59787 3Psychiatric disorders and sexual trauma are associated with lower urinary tract symptoms 59785 1Psychiatric disorders and sexual trauma are associated with lower urinary tract symptoms 59785 2Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 1Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 2
...Mo.--(BUSINESS WIRE)--May 4, 2007 - New data have,...erosis (RRMS),patients treated with COPAXONE(R) (g...osuppression with mitoxantrone experienced a,90 pe...)-monitored,disease activity compared to their bas...ere sustained throughout the 24-month study,period...
...ngland, 4th May 2007 - CeNeS Pharmaceuticals plc,(...ompany, notes,the publication of an independent st... on its Phase II NMDA antagonist, CNS 5161. CeNeS,...r neuropathic,pain. The independent study builds o...CNS 5161. , In the study reported in ,Synapse, Dr...
Other Medicine Technology:Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 2Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 3Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 4Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 5Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 6Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 7Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 2Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 3
Vitreoretinal Viscodissector 90 degrees
Infusion Cannula 6mm
DCR Set
IOL Manipulator - Sinskey
Medicine Products: